Also trades as: ESLA (NASDAQ) · $vol 0M
ESLAW NASDAQ
Estrella Immunopharma, Inc.
1W: +0.1%
1M: +49.7%
3M: -4.3%
YTD: +49.9%
1Y: +272.6%
$0.13
+0.02 (+22.64%)
Weekly Expected Move ±54.4%
$-0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Last Earnings
2026-05-18
EPS
$-0.05
▲ Beat +40.5%
Revenue
—
EPS Beat Streak: 3 quarters
Next Earnings
2026-09-02
EPS Estimate
$-0.08
Range: $-0.08 - $-0.08
Estimate vs Actual
Earnings Surprise History
5/8
EPS Beats
0/8
Revenue Beats
62%
EPS Beat Rate
0%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-04-27 | quarter | 2026-03-31 | $-0.18 | $-0.08 | ▲ 0.10 | $— | $— |
| 2026-04-27 | quarter | 2026-06-30 | $-0.17 | $-0.08 | ▲ 0.09 | $— | $— |
| 2026-03-30 | quarter | 2026-03-31 | $-0.13 | $-0.18 | ▼ 0.05 | $— | $— |
| 2026-03-30 | quarter | 2026-06-30 | $-0.12 | $-0.17 | ▼ 0.05 | $— | $— |
| 2026-03-23 | quarter | 2028-03-31 | $— | $-0.03 | ▼ 0.03 | $— | $25,705,500 |
| 2026-03-23 | quarter | 2025-12-31 | $— | $-0.18 | ▼ 0.18 | $— | $— |
| 2026-03-23 | quarter | 2027-12-31 | $— | $-0.04 | ▼ 0.04 | $— | $23,728,200 |
| 2026-03-23 | quarter | 2026-12-31 | $— | $-0.12 | ▼ 0.12 | $— | $— |
| 2026-03-23 | quarter | 2027-03-31 | $— | $-0.12 | ▼ 0.12 | $— | $— |
| 2026-03-23 | quarter | 2026-03-31 | $— | $-0.13 | ▼ 0.13 | $— | $— |
| 2026-02-11 | quarter | 2026-06-30 | $-0.08 | $-0.12 | ▼ 0.04 | $— | $— |
| 2026-02-11 | quarter | 2025-12-30 | $-0.12 | $-0.18 | ▼ 0.06 | $— | $— |
| 2026-02-11 | quarter | 2026-03-30 | $-0.08 | $-0.13 | ▼ 0.05 | $— | $— |
| 2026-02-02 | quarter | 2026-12-30 | $-0.23 | $-0.12 | ▲ 0.11 | $— | $— |
| 2026-02-02 | quarter | 2025-12-30 | $-0.18 | $-0.12 | ▲ 0.06 | $— | $— |
Earnings Call Transcripts
No transcripts available.